OR WAIT null SECS
March 21, 2022
physIQ and CellCarta are conducting a study to evaluate individual patient response to vaccination using wearable biosensors.
March 18, 2022
New report released by USP offers a look into API supply-chain vulnerabilities.
Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.
Emmes has acquired Casimir, marking its fourth major acquisition.
Sanofi and Seagen have entered an agreement to investigate three cancer targets.
March 17, 2022
Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.
Viatris’ new drug-device is the first FDA-approved generic version of AstraZeneca’s Symbicort.
BioMed X and Merck KGaA, Darmstadt, Germany announced their collaboration on a research project to study T-cells and autoimmunity.
Envirotainer and Swiss WorldCargo have successfully completed the first commercial shipment using a new temperature-controlled air freight solution.
March 16, 2022
Novasep increases its production capacity for HPAPIs with an investment in its site in Le Mans, France.